EDAP TMS (EDAP) announced the appointment of Glen French to its Board of Directors. French is a highly experienced public and private medical device and technology executive with more than 25 years of experience in the development and commercialization of diagnostic and therapeutic products.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EDAP:
- EDAP TMS Appoints Glen French to Board of Directors
- EDAP TMS, Cortechs.ai announce first OnQ prostate-assisted Focal One procedure
- EDAP TMS Reports Record Focal One® Sales and Growth in Prostate Cancer Procedures
- EDAP TMS reports preliminary Q4 sales of 11 Focal One systems
- EDAP TMS Appoints Joshua H. Levine to Board of Directors
